Cargando…
Impact of human immunodeficiency virus on pulmonary vascular disease
With the advent of anti-retroviral therapy, non-AIDS-related comorbidities have increased in people living with HIV. Among these comorbidities, pulmonary hypertension (PH) is one of the most common causes of morbidity and mortality. Although chronic HIV-1 infection is independently associated with t...
Autores principales: | Kumar, Ashok, Mahajan, Aatish, Salazar, Ethan A., Pruitt, Kevin, Guzman, Christian Arce, Clauss, Matthias A., Almodovar, Sharilyn, Dhillon, Navneet K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Magdi Yacoub Heart Foundation
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272407/ https://www.ncbi.nlm.nih.gov/pubmed/34285903 http://dx.doi.org/10.21542/gcsp.2021.12 |
Ejemplares similares
-
Human immunodeficiency virus, herpes virus infections, and pulmonary vascular disease
por: Flores, Sonia C., et al.
Publicado: (2013) -
SARS-CoV-2 and Human Immunodeficiency Virus: Pathogen Pincer Attack
por: Evans, Nicholas, et al.
Publicado: (2021) -
Mice with humanized immune system as novel models to study HIV-associated pulmonary hypertension
por: Rodriguez-Irizarry, Valerie J., et al.
Publicado: (2022) -
Pandemic response in pluralistic health systems: a cross-sectional study of COVID-19 knowledge and practices among informal and formal primary care providers in Bihar, India
por: Rao, Krishna D, et al.
Publicado: (2021) -
Correlates of access to sanitation facilities and benefits received from the Swachh Bharat Mission in India: analysis of cross-sectional data from the 2018 National Sample Survey
por: Prakash, Srayasi, et al.
Publicado: (2022)